Document is current

Any future updates will be listed below

Successful IVIG treatment without discontinuation of TNF-α blocker in Guillain-Barre syndrome induced by adalimumab in patient with Crohn’s disease

Crossref DOI link: https://doi.org/10.1007/s10072-017-3179-z

Published Online: 2017-11-03

Published Print: 2018-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark